Vimarsana
Biggest News Aggregation in the World

Page 7 - Peter Doshi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Doshi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Doshi Today - Breaking & Trending Today

Pfizer, Moderna Shots More Likely to Cause Serious Injury Than Reduce Risk of COVID-Related Hospitalization - Vimarsana News

Pfizer, Moderna Shots More Likely to Cause Serious Injury Than Reduce Risk of COVID-Related Hospitalization

A new analysis of Pfizer and Moderna COVID-19 vaccine trial data shows the risk of serious injury following the vaccine ...

Links 6/25/2022 | naked capitalism - Vimarsana News

Links 6/25/2022 | naked capitalism

Our gorgeous daily links: cat meows, mermaiding, biggest bacteria, probing self, Vonnegut doco, Covid vaccine adverse events, Covid-childhood hepatitis thesis, China loan to Pakistan, Russia accused of gaslighting, JCOPA wrangling, DC spy dates, Roe v. Wade rage, mobile homes,

Risk benefit of the vaccines is negative according to a new paper from Stanford, UCLA, others - Vimarsana News

Risk benefit of the vaccines is negative according to a new paper from Stanford, UCLA, others

Peter Doshi is an author of this paper. This paper puts my status as a "misinformation spreader" in serious jeopardy. They may have to start calling me a "truth teller" soon. [...]

Stanford, UCLA and others admit that risk benefit to covid "vaccines" is NEGATIVE - Vimarsana News

Stanford, UCLA and others admit that risk benefit to covid "vaccines" is NEGATIVE

A pre-print study authored by Peter Doshi from the University of Maryland School of Pharmacy reveals that the risk benefit to getting "vaccinated" for the Wuhan coronavirus (Covid-19) [...]

Pfizer and Moderna Analysis Re-do -- Health & Wellness -- Sott.net - Vimarsana News

Pfizer and Moderna Analysis Re-do -- Health & Wellness -- Sott.net

Peter Doshi and colleagues' heroic attempt at re-analysis of the Phase 3 trials. There has been a bit of a stir lately concerning the posting at the beginning of this month of a pre-print (not yet peer reviewed) article entitled "Serious Adverse...

Source: sott.net